Single-Cell Transcriptome Analysis of Chronic Antibody-Mediated Rejection After Renal Transplantation

• Published in: Frontiers in immunology Vol. 12; p. 767618
• Main Authors: Kong, Fanhua, Ye, Shaojun, Zhong, Zibiao, Zhou, Xin, Zhou, Wei, Liu, Zhongzhong, Lan, Jianan, Xiong, Yan, Ye, Qifa
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 17.01.2022
• Subjects: Animals; Antibodies - immunology; B-Lymphocytes - immunology; CD8-Positive T-Lymphocytes - immunology; Cell Differentiation - immunology; chronic antibody-mediated rejection (cABMR); Cytokines - immunology; end-stage renal disease; Gene Expression Profiling - methods; Graft Rejection - immunology; Humans; immunity; Immunology; Inflammation - immunology; Kidney Transplantation - methods; Macaca mulatta; Mice; Monocytes - immunology; renal transplantation; Signal Transduction - immunology; Single-Cell Analysis - methods; single-cell sequencing; single-cell transcriptome; Transcriptome - immunology; Up-Regulation - immunology; single-cell sequencing; single-cell transcriptome; immunity; end-stage renal disease; chronic antibody-mediated rejection (cABMR); renal transplantation
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2021.767618

Renal transplantation is currently the most effective treatment for end-stage renal disease. However, chronic antibody-mediated rejection (cABMR) remains a serious obstacle for the long-term survival of patients with renal transplantation and a problem to be solved. At present, the role and mechanism underlying immune factors such as T- and B- cell subsets in cABMR after renal transplantation remain unclear. In this study, single-cell RNA sequencing (scRNA-seq) of peripheral blood monocytes (PBMCs) from cABMR and control subjects was performed to define the transcriptomic landscape at single-cell resolution. A comprehensive scRNA-seq analysis was performed. The results indicated that most cell types in the cABMR patients exhibited an intense interferon response and release of proinflammatory cytokines. In addition, we found that the expression of MT-ND6, CXCL8, NFKBIA, NFKBIZ, and other genes were up-regulated in T- and B-cells and these genes were associated with pro-inflammatory response and immune regulation. Western blot and qRT-PCR experiments also confirmed the up-regulated expression of these genes in cABMR. GO and KEGG enrichment analyses indicated that the overexpressed genes in T- and B-cells were mainly enriched in inflammatory pathways, including the TNF, IL-17, and Toll-like receptor signaling pathways. Additionally, MAPK and NF-κB signaling pathways were also involved in the occurrence and development of cABMR. This is consistent with the experimental results of Western blot. Trajectory analysis assembled the T-cell subsets into three differentiation paths with distinctive phenotypic and functional prog rams. CD8 effector T cells and γδ T cells showed three different differentiation trajectories, while CD8_MAI T cells and naive T cells primarily had two differentiation trajectories. Cell-cell interaction analysis revealed strong T/B cells and neutrophils activation in cABMR. Thus, the study offers new insight into pathogenesis and may have implications for the identification of novel therapeutic targets for cABMR.